Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

NCT02489331 · clinicaltrials.gov ↗
COMPLETED
Status
193
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Abbott